BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials

Clinical Cancer Research

Volumn 13, Issue 24, 2007, Pages 7357-7362

  Tilanus Linthorst, Madeleine M A ^a   Obdeijn, Inge Marie ^a   Hop, Wim C J ^a   Causer, Petrina A ^b   Leach, Martin O ^d   Warner, Ellen ^c   Pointon, Linda ^d   Hill, Kimberley ^c   Klijn, Jan G M ^a   Warren, Ruth M L ^e   Gilbert, Fiona J ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Centre for Research on Women's Health   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER RISK; FEMALE; GENE MUTATION; HEREDITY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MUTAGENESIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CANADA; CELL PROLIFERATION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MIDDLE AGED; MUTATION; NETHERLANDS;

EID: 37549026190     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0689     Document Type: Article

References (32)

1. Antoniou A, Pharaoh P, Narod S, et al. Average risk of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
2. Eerola H, Vahteristo P, Sarantaus L, et al. Survival of breast cancer patients in BRCA1, BRCA2 and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int J Cancer 2001;93:368-72.
3. Kriege M, Brekelmans CTM, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-37.
4. Leach MO, Boggis CR, Dixon AK, et al.; MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769-78.
5. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA 2004;292:1317-25.
6. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:8469-76.
7. Hagen AI, Kvistad KA, Maehle L, et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 2007;16:367-74.
8. Brekelmans CTM, Seynaeve C, Menke-Pluymers M, et al. Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 2006;17:391-400.
9. Tilanus-Linthorst MMA, Alves C, Seynaeve C, Menke-Pluymers MBE, Eggermont AMM, Brekelmans CTM. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer. Br J Surg 2006;93:961-8.
10. Maurice A, Evans DG, Shenton A, et al. Screening younger women with a family history of breast cancer - does early detection improve outcome? Eur J Cancer 2006;42:1385-90.
11. Tilanus-Linthorst MM, Obdeijn I-M, Bartels KCM. MARIBS study. Lancet 2005;366:291-2 and 1434.
12. Tilanus-Linthorst MM, Kriege M, Boetes C, et al. Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer 2005;41:1610-7.
13. Duffy SW, Day NE, Tabar L, et al. Markov models of breast tumor progression: some age-specific results. Monogr Natl Cancer Inst 1997;22:93-7.
14. Kopans DB, Rafferty E, Georgian-Smith D, et al. A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer 2003;97:2951-9.
15. Michaelson JS, Halpern E, Kopans D. Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology 1999;212:551-60.
16. Eerola H, Heikkilä P, Tamminen A, Aittomäki K, Blomqvist C, Nevanlinna H. Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families. Breast Cancer Res 2005;7:R465-69.
17. Lakhani SR, Jacqumier J, Sloane JP, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998;90:1138-45.
18. Brekelmans CTM, Tilanus-Linthorst MMA, Seynaeve C, et al. Tumour characteristics, survival and prognostic factors of hereditary breast cancers from BRCA2-, BRCA1-, and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer 2007;43:867-76.
19. Rebbeck TR, Friebel T, Wagner Th, et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 2005;23:7804-10.
20. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976;37:2486-92.
21. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-36.
22. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94.
23. Mitchell G, Antoniou AC, Warren R, et al. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 2006;66:1866-72.
24. Shekhar MPV, Werdell J, Santer SJ, Pauley RJ, Tait I. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 2001;61:1320-6.
25. Dong-Le Bourhis X, Bertthois Y, Millot G, et al. Effects of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer 1997;71:42-8.
26. Peer PG, van Dijck JA, Hendriks JH, Holland R, Verbeek AL. Age-dependent growth rate of primary breast cancer. Cancer 1993;71:3547-51.
27. Norton LA. Gompertzian model of human breast cancer growth. Cancer Res 1988;48:7067-71.
28. Hart D, Shochat E, Agur Z. The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer 1998;78:38207.
29. Tubiana M, Koscielny S. Natural history of human breast cancer: recent data and clinical implications. Breast Cancer Res Treat 1991;18:125-40.
30. Tabar L, Fagerberg G, Day NE, et al. Breast cancer treatment and natural history: new insights from results of screening. Lancet 1992;339:412-4.
31. Spratt JA, von Fournier D, Spratt JS, et al. Mammographic assessment of human breast cancer growth and duration. Cancer 1993;71:2020-6.
32. White E, Miglioretti DL, Yankaskas BC, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004;96:1832-9.